These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16162405)

  • 1. Erosion of the principal investigator role in a climate of industry dominance.
    Rowinsky EK
    Eur J Cancer; 2005 Oct; 41(15):2206-9. PubMed ID: 16162405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The difficulties industry is facing with investigators.
    Blackledge GR
    Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scripps Florida.
    Sheppard TL
    Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 5. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hunt for a new drug: five views from the inside.
    Mervis J
    Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial interest waxes for IGF-1 blockers.
    Osborne R
    Nat Biotechnol; 2008 Jul; 26(7):719-20. PubMed ID: 18612276
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.
    Adam M
    Stud Hist Philos Biol Biomed Sci; 2005 Sep; 36(3):513-37. PubMed ID: 16137601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer drug discovery through collaboration.
    Lengauer C; Diaz LA; Saha S
    Nat Rev Drug Discov; 2005 May; 4(5):375-80. PubMed ID: 15864266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development.
    Markman M
    Cancer; 2008 May; 112(9):1871-3. PubMed ID: 18318430
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of genomics in clinical trial design.
    Simon R
    Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging to biomarker development in neuroscience.
    Frost JJ
    Ann N Y Acad Sci; 2008 Nov; 1144():251-5. PubMed ID: 19076382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic development: a victim of market forces?
    Tillotson GS
    IDrugs; 2008 May; 11(5):340-6. PubMed ID: 18465675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium review: drug discovery, development and clinical research in academia.
    Vlaar CP; Hernández L
    P R Health Sci J; 2009 Sep; 28(3):268-73. PubMed ID: 19715120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the large pharmaceutical and biotechnology companies driving the discovery, research and development of targeted cancer therapies?
    Gallant GJ
    Future Med Chem; 2012 Jan; 4(1):13-7. PubMed ID: 22168161
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical research opportunities: what you need to know for your practice.
    Glatz NF; Gregory SJ; Law BT; Riner RN
    Heart Dis; 2000; 2(4):287-92. PubMed ID: 11728271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.